Stillwater Capital Advisors LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 5.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 38,677 shares of the healthcare conglomerate’s stock after selling 2,157 shares during the quarter. UnitedHealth Group accounts for about 3.2% of Stillwater Capital Advisors LLC’s holdings, making the stock its 7th largest position. Stillwater Capital Advisors LLC’s holdings in UnitedHealth Group were worth $19,724,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in the business. State Street Corp boosted its holdings in UnitedHealth Group by 1.9% in the 4th quarter. State Street Corp now owns 45,559,868 shares of the healthcare conglomerate’s stock valued at $22,877,432,000 after purchasing an additional 869,827 shares in the last quarter. Capital International Investors boosted its stake in shares of UnitedHealth Group by 4.3% during the 4th quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock worth $9,713,058,000 after acquiring an additional 790,219 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of UnitedHealth Group by 1.2% during the 4th quarter. Geode Capital Management LLC now owns 15,618,069 shares of the healthcare conglomerate’s stock worth $7,821,210,000 after acquiring an additional 189,864 shares in the last quarter. Alliancebernstein LP boosted its stake in shares of UnitedHealth Group by 2.4% during the 4th quarter. Alliancebernstein LP now owns 11,015,163 shares of the healthcare conglomerate’s stock worth $5,531,154,000 after acquiring an additional 257,910 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $4,478,185,000. 87.48% of the stock is currently owned by institutional investors.
UNH stock opened at $517.40 on Friday. The company has a market cap of $485.41 billion, a price-to-earnings ratio of 28.32, a PEG ratio of 1.54 and a beta of 0.83. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.54. The business has a fifty-day simple moving average of $492.77 and a 200-day simple moving average of $492.61. UnitedHealth Group Incorporated has a 52 week low of $383.12 and a 52 week high of $553.29.
UnitedHealth Group (NYSE:UNH – Get Rating) last announced its quarterly earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.40 by $0.09. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The firm had revenue of $80.15 billion during the quarter, compared to the consensus estimate of $78.77 billion. During the same period in the previous year, the firm earned $5.31 EPS. The firm’s quarterly revenue was up 14.2% compared to the same quarter last year. As a group, analysts expect that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 28th. Investors of record on Monday, June 20th were issued a $1.65 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 annualized dividend and a yield of 1.28%. The ex-dividend date of this dividend was Thursday, June 16th. UnitedHealth Group’s dividend payout ratio is currently 36.12%.
In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,273 shares of the company’s stock in a transaction dated Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total value of $635,227.00. Following the completion of the transaction, the executive vice president now directly owns 8,104 shares of the company’s stock, valued at approximately $4,043,896. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $493.25, for a total transaction of $1,233,125.00. Following the completion of the transaction, the director now directly owns 1,220,000 shares of the company’s stock, valued at $601,765,000. The disclosure for this sale can be found here. Over the last quarter, insiders sold 6,273 shares of company stock valued at $3,065,752. 0.40% of the stock is owned by insiders.
Several equity research analysts have recently commented on the company. Raymond James boosted their price target on UnitedHealth Group from $540.00 to $620.00 and gave the stock a “strong-buy” rating in a research note on Tuesday, April 19th. Barclays raised their target price on UnitedHealth Group from $495.00 to $565.00 and gave the company an “overweight” rating in a research note on Wednesday, March 30th. Wells Fargo & Company reduced their target price on UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 25th. Morgan Stanley raised their target price on UnitedHealth Group from $570.00 to $577.00 and gave the company an “overweight” rating in a research note on Monday, April 18th. Finally, SVB Leerink raised their target price on UnitedHealth Group from $550.00 to $600.00 and gave the company an “outperform” rating in a research note on Tuesday, April 19th. Three research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $555.73.
UnitedHealth Group Profile: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments. UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.